Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies



Rating:

Share or cite this content

Citations should be made in the following way:
L. Sher (Rolling Hills Estates, CA, United States of America), G. Passalacqua (Genoa, Italy), C. Taillé (Paris, France), L. Cohn (New Haven, CT, United States of America), S. Quirce (Madrid, Spain), N. Daizadeh (Cambridge, MA, United States of America), N. Pandit-Abid (Bridgewater, NJ, United States of America), B. Ortiz (Tarrytown, NY, United States of America), A. Khan (Chilly-Mazarin, France), Y. Zhang (Tarrytown, NY, United States of America). Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma. 3733

Member's Comments

No comment yet.

Related content which might interest you: Effect of dupilumab on improving physical activity in patients with severe asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 The effects of formoterol/budesonide on sleep quality of COPD patients Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Daytime physical activity and sleep quality as related to patient-reported and physiological outcomes following severe COPD exacerbation Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021 Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma: Results from a phase 2a trial Source: International Congress 2016 – Best abstracts in asthma and COPD Year: 2016 Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Poor quality of life is associated with frequent exacerbations in moderate-to-severe COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 190s Year: 2001 Patient-reported versus objective adherence and exacerbation rates in severe asthma. Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 Impact of omalizumab in patients with severe asthma Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Effect of night symptoms and disease severity on sleep quality in children with bronchiectasis Source: Annual Congress 2010 - Adenotonsillectomy and paediatric sleep medicine Year: 2010 Impact of nighttime and early morning symptoms on HRQoL and work productivity of COPD patients Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 72s Year: 2007 Differences in proxy-reported and patient-reported outcomes: Assessing problematic activities of daily life in patients with COPD Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences Year: 2016 Correlation between indices of quality of life and degree of severity of symptoms in patients with asthma in combination with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 520s Year: 2004 Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Poor sleep quality in COPD: related factors and its effects on COPD patients Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Respiratory symptoms are associated with impaired health-related quality of life in subjects with neither asthma nor COPD Source: Annual Congress 2009 - Risk factors for asthma and pneumonia Year: 2009 Effect of asthma and asthma medication on the prognosis of patients with COVID-19 Source: Eur Respir J, 57 (3) 2002226; 10.1183/13993003.02226-2020 Year: 2021 Comparison of fatigue and sleep quality between COPD and healthy subjects Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment methods in COPD and asthma Year: 2013